Mentor Research Institute

Healthy Contracts Legislation; Measurement & Value-Based Payment Contracting: Online Screening & Outcome Measurement Software

503 227-2027

Arguments and Evidence Supporting the Feasibility of a Qui Tam Action Based on Information Provided for Healthy Contacts Legislation

A Discussion Paper


Summary

  • The information provided to support the Healthy Contacts legislation offers substantial evidence of potential fraud by health plans, particularly Moda Health.

  • Misrepresentation of contract terms, unethical offers to providers, data manipulation, and creating a false appearance of value-based contracting all point to violations of the False Claims Act.

  • These actions not only defraud government programs but also impose significant burdens on providers and harm public health.

  • A qui tam action is feasible and justified based on this evidence, allowing whistleblowers to expose these fraudulent practices and hold the responsible parties accountable.

The Healthy Contacts legislation highlights instances where Healthplans, including Moda Health, may have misrepresented the nature of their contracts to obtain funding from the state. Misleading contract terms that inflate the effectiveness or compliance with value-based care principles can constitute a false claim. Misrepresentation to secure government funds is a clear violation of the False Claims Act (FCA), making a qui tam action feasible. The FCA specifically targets entities that submit false claims for government reimbursement, and misrepresenting contract terms to obtain funding falls squarely within this category.

The legislation suggests that health plans offer misleading and unethical contracts to providers, causing them to submit claims under false pretenses. These contracts may promise certain value, benefits or reimbursement rates that are not delivered. Providers submitting claims based on false contract terms are unknowingly part of the fraud. A qui tam action can expose the health plan's role in inducing these false claims, holding them accountable under the FCA.

The Healthy Contacts legislation outlines how health plans manipulate performance metrics and selectively withhold data to support their financial interests. This can lead to unjust denials of legitimate claims and financial penalties for providers. Manipulating data to secure government funds or to disadvantage providers in contract negotiations is fraudulent. A qui tam action can address the Healthplan’s deceptive practices that result in financial harm to government programs.

The additional costs imposed on providers by complying with ambiguous and misleading contracts with increased administrative burdens are highlighted in the legislation proposal. These practices can reduce the availability of care and compromise care quality. The financial strain and administrative burdens resulting from fraudulent contract terms can be presented as part of the evidence in a qui tam action, demonstrating how the health plan’s practices harm providers and, by extension, government-funded healthcare programs.

Moda Health is accused of creating a false appearance of value-based contracts to win contracts funded by taxpayer dollars, despite evidence that these contracts will likely fail. This misrepresentation to secure government funding constitutes a false claim. By demonstrating that the health plan knowingly presented flawed contracts to obtain funding, a qui tam action can hold them accountable for defrauding the government.

The legislation underscores the erosion of trust between providers and health plans due to these unethical practices. This adversarial relationship can lead to disengagement and reduced care quality. The broader impact on public health and the integrity of government healthcare programs can be compelling points in a qui tam action. Demonstrating how fraudulent practices undermine public trust and healthcare quality strengthens the case.

The information provided to support the Healthy Contacts legislation offers substantial evidence of potential fraud by health plans, particularly Moda Health. Misrepresentation of contract terms, unethical offers to providers, data manipulation, and creating a false appearance of value-based contracting all point to violations of the False Claims Act. These actions not only defraud government programs but also impose significant burdens on providers and harm public health. A qui tam action is feasible and justified based on this evidence, allowing whistleblowers to expose these fraudulent practices and hold the responsible parties accountable.


Outline

1. Misrepresentation of Contract Terms

  • Evidence: The Healthy Contacts legislation highlights instances where health plans, including Moda Health, may have misrepresented the nature of their contracts to obtain funding from the state. Misleading contract terms that inflate the effectiveness or compliance with value-based care principles can constitute a false claim.

  • Argument: Misrepresentation to secure government funds is a clear violation of the False Claims Act (FCA), making a qui tam action feasible. The FCA specifically targets entities that submit false claims for government reimbursement, and misrepresenting contract terms to obtain funding falls squarely within this category.

2. Unethical and Misleading Offers to Providers

  • Evidence: The legislation suggests that health plans offer misleading and unethical contracts to providers, causing them to submit claims under false pretenses. These contracts may promise certain benefits or reimbursement rates that are not delivered.

  • Argument: Providers submitting claims based on false contract terms are unknowingly part of the fraud. A qui tam action can expose the health plan's role in inducing these false claims, holding them accountable under the FCA.

3. Data Manipulation and Withholding

  • Evidence: The Healthy Contacts legislation outlines how health plans manipulate performance metrics and selectively withhold data to support their financial interests. This can lead to unjust denials of legitimate claims and financial penalties for providers.

  • Argument: Manipulating data to secure government funds or to disadvantage providers in contract negotiations is fraudulent. A qui tam action can address the health plan’s deceptive practices that result in financial harm to government programs.

4. Financial and Administrative Burdens Imposed on Providers

  • Evidence: The additional costs imposed on providers by complying with misleading contracts and increased administrative burdens are highlighted in the legislation. These practices can reduce the availability of care and compromise care quality.

  • Argument: The financial strain and administrative burdens resulting from fraudulent contract terms can be presented as part of the evidence in a qui tam action, demonstrating how the health plan’s practices harm providers and, by extension, government-funded healthcare programs.

5. Creating a False Appearance of Value-Based Contracting

  • Evidence: Moda Health is accused of creating a false appearance of value-based contracts to win contracts funded by taxpayer dollars, despite evidence that these contracts will likely fail.

  • Argument: This misrepresentation to secure government funding constitutes a false claim. By demonstrating that the health plan knowingly presented flawed contracts to obtain funding, a qui tam action can hold them accountable for defrauding the government.

6. Erosion of Trust and Impact on Public Health

  • Evidence: The legislation underscores the erosion of trust between providers and health plans due to these unethical practices. This adversarial relationship can lead to disengagement and reduced care quality.

  • Argument: The broader impact on public health and the integrity of government healthcare programs can be compelling points in a qui tam action. Demonstrating how fraudulent practices undermine public trust and healthcare quality strengthens the case. 

Key words: Supervisor education, Ethics, COVID Office Air Treatment, Mental Health, Psychotherapy, Counseling, Patient Reported Outcome Measures,